Almac Expects High Sales Growth, Especially in U.S.

Almac (Craigavon, U.K.), a privately owned pharmaceutical services group, says it is on track to grow sales significantly during the next few years and in the U.S. in particular. Group sales increased 16% in 2007, to £150.1 million ($293 million), and are expected to rise a further 20% this year, the company said at a press briefing, held recently at its Craigavon headquarters. Almac says its long-term goal is to expand its U.S. market presence. The firm’s largest single capital investment this year is a proposed $100-million project to build a U.S...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers